Call for Abstracts
Call for Abstracts
The Committee of the 67th Annual Meeting of the JSN encourages abstract submission widely from overseas. All the abstracts submitted are rated and selected for presentation by the Committee.
The abstract is only submitted by online. The submission of abstracts by e-mail will NOT be considered. The abstract should be written in English.
Regular Submission
Nov. 7 (Tue), 2023 - at 2:00 p.m. JST on Dec. 26 (Tue), 2023
Regular Submission
The deadline for regular submission is scheduled at 2:00 p.m. JST on Dec. 25 (Mon), 2023.
Please select preferred presentation style, Oral or Poster, when you submit an abstract.
However, please note that the presentation style will be decided by the congress chairperson.
Please be aware that encore abstracts will NOT be accepted.
Presentation style
- Oral presentation：Presentation and discussion at venue (8mins Presentation+ 4mins Discussion, Total 12mins)
- Poster presentation：Displaying poster and discussion at venue (4mins Presentation+ 2mins Discussion, Total 6mins)
Best Abstract Awards
All the abstracts submitted are rated by the Abstract Review Committee and the Committee honors high scored abstracts with Best abstract awards.
The awardees are to present their research in English as Oral presentations.
*Application Review Considerations
All abstracts will be reviewed in the same manner. Abstract acceptance is determined by the Congress Chairperson 2024, based on the reviews from the Abstract Review Committee commissioned by the Congress Chairperson.
Please note that the congress will not offer the authors of regular submission any grants and any support for their VISA application. The accepted authors are requested to bear all expenses to attend the congress such as their transportation, accommodation and registration.
1. Maximum number of authors and institutions
| Authors | 18 persons (including the first author) |
|---|---|
| Institutions | 10 centers |
2. Limitations of number of words
| Abstract Title | 50 words |
|---|---|
| Abstract Body | 250 words |
| Total number of words (including authors, institutions, title and abstract body) |
300 words |
3. COI disclosure
You are requested to show whether there is any conflicts of interest on medical researches and publications by clicking a check box when your abstract submission.
Please refer to the detailed regulations.
4. Password
To create your password is required. Password should be case-sensitive and must be between 6 and 8 character long. The password is necessary for you to view or modify your abstract.
For security reason, we cannot tell anyone's password. Please make sure to make a copy or back up of your password when submitting an abstract.
5. Receipt of Abstract / Notifying the result
Receipt of abstract will be automatically sent to the registered e-mail address. We strongly advise you to confirm the contents that you submit.
The result of review will be notified all candidates via e-mail. Please make sure to register accurate e-mail address.
6. Category of Regular Submission
We accept submission of English abstracts to regular session.
| 【CKD】 | |
|---|---|
| 101 | CKD (non-dialysis; basic) |
| 102 | CKD (non-dialysis; clinical) |
| 103 | Anemia and iron metabolism |
| 104 | Others |
| 【ESRD】 | |
|---|---|
| 201 | Hemodialysis |
| 202 | Peritoneal dialysis |
| 203 | Renal transplantation |
| 204 | Apheresis |
| 205 | Others |
| 【AKI】 | |
|---|---|
| 301 | AKI (basic) |
| 302 | AKI (clinical) |
| 【Glomerular / Tubulointerstitial Diseases (Primary and Secondary included DKD)】 | |
|---|---|
| 401 | Primary glomerular diseases (basic) |
| 402 | Primary glomerular diseases (clinical) |
| 403 | Secondary glomerular diseases (basic) |
| 404 | Secondary glomerular diseases (clinical) |
| 405 | Tubulointerstitial diseases |
| 406 | Drug-induced kidney diseases (basic) |
| 407 | Drug-induced kidney diseases (clinical) |
| 408 | DKD (basic) |
| 409 | DKD (clinical) |
| 410 | Others |
| 【Pediatric / Genetic / Cystic / Urological Diseases】 | |
|---|---|
| 501 | Pediatric nephrology |
| 502 | Genetic kidney diseases: cystic |
| 503 | Genetic kidney diseases: non-cystic |
| 504 | Urological diseases |
| Fluid, Electrolyte, and Acid-base / Mineral and Bone Disorders】 | |
|---|---|
| 601 | Fluid, electrolytes, and acid-base disorders (basic) |
| 602 | Fluid, electrolytes, and acid-base disorders (clinical) |
| 603 | Bone and mineral diseases (basic) |
| 604 | Bone and mineral diseases (clinical) |
| 【Hypertension / Cardiovascular Diseases】 | |
|---|---|
| 701 | Hypertension (basic) |
| 702 | Hypertension (clinical) |
| 703 | Cardiovascular diseases (basic) |
| 704 | Cardiovascular diseases (clinical) |
| 【Interdisciplinary Care / Patients Association】 | |
|---|---|
| 801 | Education and health guidance for CKD |
| 802 | Community Health Care |
| 803 | Laboratory medicine |
| 804 | Others |
| 【Basic Science】 | |
|---|---|
| 901 | Genetics/Development |
| 902 | Stem Cells/Regeneration |
| 903 | Extracellular Matrix/Fibrosis |
| 904 | Immunity/Inflammation |
| 905 | Hormone/Cell Signaling |
| 906 | Others |
7. Keyword
Please state up to three keywords of your abstract. (at least one keyword is mandatory)
8. Submit, Confirm and Modify Abstracts
SSL
Non SSL
(If you cannot use cipher-text-based.)